Armenia vs Northern Africa and Western Asia: Proportion of the target population who received a 3rd dose of
Armenia
94.0%
in 2024
Northern Africa and Western Asia
50.0%
in 2024
Armenia rank
36th
Northern Africa and Western Asia rank
33rd
Proportion of the target population who received a 3rd dose of over time
- Armenia
- Northern Africa and Western Asia
How they compare
Armenia currently reports 94.0% against 50.0% in Northern Africa and Western Asia, a difference of 44.0%.
That makes Armenia's figure about 1.9 times Northern Africa and Western Asia's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Northern Africa and Western Asia ahead.
Armenia ranks 36th and Northern Africa and Western Asia ranks 33rd of 157 countries.
Armenia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Armenia | Northern Africa and Western Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 83.2% | 54.2% | 29.0% | Armenia |
| 2020s | 93.2% | 50.6% | 42.6% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Armenia or Northern Africa and Western Asia?
- Armenia, at 94.0% against 50.0% in Northern Africa and Western Asia as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Armenia and Northern Africa and Western Asia?
- 44.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Northern Africa and Western Asia?
- 10 years are reported by both, from 2015 to 2024.
- How do Armenia and Northern Africa and Western Asia rank globally for proportion of the target population who received a 3rd dose of?
- Armenia ranks 36th and Northern Africa and Western Asia ranks 33rd of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.